{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:25:18Z","timestamp":1793499918105,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jchf.2025.102515","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T15:25:42Z","timestamp":1750433142000},"page":"102515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure"],"prefix":"10.1016","volume":"13","author":[{"given":"Alessandro","family":"Villaschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-0253","authenticated-orcid":false,"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-6023","authenticated-orcid":false,"given":"Cecilia","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Zieroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Gadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0887","authenticated-orcid":false,"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102515_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1503\/cmaj.101685","article-title":"Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials","volume":"183","author":"Wells","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jchf.2025.102515_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejheart.2005.11.014","article-title":"Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction\u2014a systematic review and meta-analysis","volume":"8","author":"Freemantle","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib3","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102515_bib4","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102515_bib5","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/europace\/euu300","article-title":"Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association","volume":"17","author":"Raatikainen","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jchf.2025.102515_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jchf.2017.02.018","article-title":"Impact of current versus previous cardiac resynchronization therapy guidelines on the proportion of patients with heart failure eligible for therapy","volume":"5","author":"Lyons","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2459\/JCM.0000000000001231","article-title":"Impact of QRS duration on left ventricular remodelling and survival in patients with heart failure","volume":"22","author":"Straw","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jchf.2025.102515_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jacc.2017.11.020","article-title":"Impaired recovery of left ventricular function in patients with cardiomyopathy and left bundle branch block","volume":"71","author":"Sze","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102515_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/pace.13264","article-title":"New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: the NEOLITH II study","volume":"41","author":"Wang","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jchf.2025.102515_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/clc.23135","article-title":"Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes","volume":"42","author":"Goldstein","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jchf.2025.102515_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad059","article-title":"Timing of cardiac resynchronization therapy implantation","volume":"25","author":"Leyva","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jchf.2025.102515_bib12","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.781","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/ehjqcco\/qcad024","article-title":"What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II","volume":"9","author":"Gatti","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jchf.2025.102515_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jacep.2022.05.001","article-title":"Guideline-directed medical therapy and the risk of death in primary prevention defibrillator recipients","volume":"8","author":"Dhande","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jchf.2025.102515_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/europace\/euu233","article-title":"Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry","volume":"17","author":"Gadler","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jchf.2025.102515_bib17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jchf.2025.102515_bib18","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102515_bib19","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1093\/eurheartj\/ehae334","article-title":"Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization Study","volume":"45","author":"Veltmann","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102515_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium","volume":"22","author":"Abraham","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ejhf.2477","article-title":"Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry","volume":"24","author":"D\u2019Amario","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102515_bib23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/ejhf.3295","article-title":"How to tackle therapeutic inertia in heart failure with reduced ejection fraction: a scientific statement of the Heart Failure Association of the ESC","volume":"26","author":"Savarese","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102515_bib25","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jchf.2025.102515_bib26","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.102515_bib27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jchf.2024.08.010","article-title":"Cardiac resynchronization therapy in ischemic versus nonischemic cardiomyopathy: patient-level meta-analysis of 7 randomized clinical trials","volume":"12","author":"Sudesh","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/eurheartj\/ehn577","article-title":"The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial","volume":"30","author":"Wikstrom","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102515_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.104.520817","article-title":"Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE)","volume":"113","author":"Sutton","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102515_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000937","article-title":"Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"6","author":"Mustafa","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2025.102515_bib31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ejhf.838","article-title":"The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets","volume":"19","author":"Zaman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/heartjnl-2012-302807","article-title":"Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response","volume":"99","author":"Verbrugge","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2025.102515_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031179","article-title":"Temporal trends in heart failure management and outcomes: insights from a Japanese multicenter registry of tertiary care centers","volume":"12","author":"Nakamaru","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102515_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ejhf.3506","article-title":"Trends in heart failure mortality in Sweden between 1997 and 2022","volume":"27","author":"Lindberg","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102515_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12933-023-01970-w","article-title":"Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies","volume":"22","author":"Carluccio","year":"2023","journal-title":"Cardiovasc Diabetol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925004421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925004421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:39:05Z","timestamp":1760074745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925004421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213177925004421"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102515","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102515"}}